CLINICAL FEATURES OF HEPATITIS C VIRUS CARRIERS WITH PERSISTENTLY NORMAL ALANINE AMINOTRANSFERASE LEVELS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

UTO HIROFUMI; MAWATARI SEIICH; KUMAGAI KOTARO; IDO AKIO; TSUBOUCHI HIROHITO

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Hepatitis Monthly Year:2012 | Volume:12 | Issue:2 Page(s): 77-84

Download Full-Text

View:

308

Download:

250

Cites:

Information Journal Paper

Title

CLINICAL FEATURES OF HEPATITIS C VIRUS CARRIERS WITH PERSISTENTLY NORMAL ALANINE AMINOTRANSFERASE LEVELS

Author(s)

Keywords

HEPATITIS C

ALANINE TRANSAMINASE

CLINICAL PROTOCOLS

LIVER CIRRHOSIS

Abstract

HEPATITIS C virus (HCV) infection causes chronic hepatitis, which frequently leads to hepatic fibrosis and hepatocellular carcinoma (HCC). Alanine aminotransferase (ALT) is a biomarker of hepatocyte injury and is associated with the progression of hepatic fibrosis.Advanced hepatic fibrosis also predisposes HCV carriers to a risk of HCC. In contrast, some cases with persistent HCV infection have normal ALT levels that persist for a long time, and these HCV carriers have no or mild hepatitis and hepatic fibrosis. These HCV carriers are defined as persistent normal ALT (PNALT) cases and their risk of HCC is low compared to HCV carriers with abnormal ALT. However, there are various definitions of normal ALT and PNALT, and advanced hepatic fibrosis may be missed without a liver biopsy.In addition, there is also a risk of ALT elevation in HCV carriers with PNALT, which increases the risk of progression to hepatic fibrosis and HCC. Most HCV carriers with PNALT have asymptomatic or nonspecific symptoms. HCV carriers with PNALT are also considered to be responsive to interferon-based treatment. Thus, assessment of hepatic fibrosis is important in HCV carriers, and the eradication of HCV infection is more likely in HCV carriers with evidence of hepatic fibrosis, regardless of their ALT levels.

Cites

No record.

References

No record.

Cite

APA: Copy

UTO, HIROFUMI, MAWATARI, SEIICH, KUMAGAI, KOTARO, IDO, AKIO, & TSUBOUCHI, HIROHITO. (2012). CLINICAL FEATURES OF HEPATITIS C VIRUS CARRIERS WITH PERSISTENTLY NORMAL ALANINE AMINOTRANSFERASE LEVELS. HEPATITIS MONTHLY, 12(2), 77-84. SID. https://sid.ir/paper/306565/en

Vancouver: Copy

UTO HIROFUMI, MAWATARI SEIICH, KUMAGAI KOTARO, IDO AKIO, TSUBOUCHI HIROHITO. CLINICAL FEATURES OF HEPATITIS C VIRUS CARRIERS WITH PERSISTENTLY NORMAL ALANINE AMINOTRANSFERASE LEVELS. HEPATITIS MONTHLY[Internet]. 2012;12(2):77-84. Available from: https://sid.ir/paper/306565/en

IEEE: Copy

HIROFUMI UTO, SEIICH MAWATARI, KOTARO KUMAGAI, AKIO IDO, and HIROHITO TSUBOUCHI, “CLINICAL FEATURES OF HEPATITIS C VIRUS CARRIERS WITH PERSISTENTLY NORMAL ALANINE AMINOTRANSFERASE LEVELS,” HEPATITIS MONTHLY, vol. 12, no. 2, pp. 77–84, 2012, [Online]. Available: https://sid.ir/paper/306565/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops